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Systematic Review or Meta-Analysis
Adverse events in meditation practices and
meditation-based therapies: a systematic
review
Farias M, Maraldi E, Wallenkampf KC, Lucchetti G. Adverse events in
meditation practices and meditation-based therapies: a systematic
review.
Objective: Meditation techniques are widely used as therapy and
wellbeing practices, but there are growing concerns about its potential
for harm. The aim of the present study is to systematically review
meditation adverse events (MAEs), investigating its major clinical
categories and its prevalence.
Method: We searched PubMed, PsycINFO, Scopus, Embase and
AMED up to October 2019. Eligible studies included original reports of
meditation practices (excluding related physical practices such as Yoga
postures) with adult samples across experimental, observational and
case studies. We identified a total of 6742 citations, 83 of which met the
inclusion criteria for MAEs with a total of 6703 participants who
undertook meditation practice.
Results: Of the 83 studies analysed, 55 (65%) included reports of at
least one type of MAE. The total prevalence of adverse events was
8.3% (95% CI 0.05–0.12), though this varied considerably across types
of studies – 3.7% (95% CI 0.02–0.05) for experimental and 33.2% (95%
CI 0.25–0.41) for observational studies. The most common AEs were
anxiety (33%, 18), depression (27%, 15) and cognitive anomalies (25%,
14); gastrointestinal problems and suicidal behaviours (both 11%, 6)
were the least frequent.
Conclusion: We found that the occurrence of AEs during or after
meditation practices is not uncommon, and may occur in individuals
with no previous history of mental health problems. These results are
relevant both for practitioners and clinicians, and contribute to a
balanced perspective of meditation as a practice that may lead to both
positive and negative outcomes.
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Summations
• Meditation practices are associated with the report of adverse events, particularly anxiety and depres-
sion.
• The overall prevalence of meditation adverse events (8.3%) is similar to those reported for psy-
chotherapy practice in general.
Considerations
• There is no standard assessment of adverse events in the reviewed literature, and randomized con-
trolled trials are likely to under-report them.
• Future research should focus on how meditation outcomes are affected by context and individual dif-
ferences, including appraisals of meditation experiences.
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Originally developed as a technique for spiritual
contemplation, meditation is now widely used as a
wellbeing and therapeutic practice. The 2012 US
National Health Statistics reported that 8% of US
adults (18 million) have used some type of medita-
tion technique (1). While the major concern of the
research literature has been to establish the physi-
cal and mental health benefits of meditation prac-
tices, there have been reports about its potential
for harm stretching back to the 1970s (2, 3). In
1977, the American Psychiatric Association pub-
lished a position statement on meditation where it
strongly recommended that ’research be under-
taken in the form of well-controlled studies to eval-
uate the possible specific usefulness, indication,
contraindications, and dangers of meditative tech-
niques’. Yet it has taken almost four decades of
research before the literature acknowledged that
there might be a bias towards exaggerating the
clinical benefits of meditation practice and dismiss-
ing its potential adverse effects (4–6).
Although there is a wide range of meditation
techniques originally developed across religious
traditions, for the past 50 years the study of medi-
tation has overwhelmingly focused on two tech-
niques derived from Hindu and Buddhist
traditions: transcendental meditation and mindful-
ness (7). More recently, there has been a growing
interest in studying techniques associated with
prosocial emotions and behaviours, such as loving-
kindness and compassion meditation (8). Different
types of meditation are likely to engage diverse
cognitive mechanisms (9, 10) and have been found
to be associated with contrasting neural correlates,
an exception being the common recruitment of the
insula across meditation types, a region involved in
awareness of inner body states (11).
Meditation practices have been linked to the
triggering of unusual or extraordinary states of
mind, though not all positive (12, 13). Historical
reports indicate that it has been used to deperson-
alize soldiers (14) and that some individuals can
develop a ‘meditation sickness’ (15). The first
handbook of meditation included contributions
from leading cognitive psychotherapists (e.g. A
Lazarus and A Ellis) about the occurrence of
adverse events associated with these practices (16).
Despite this early interest in meditation adverse
events (MAEs), the prevailing reports of medita-
tion for most of the last 20 years have largely
ignored the possibility of these effects or even
denied it (17). It is only more recently that clini-
cians and academic centres dedicated to the study
of meditation-based interventions have begun
acknowledging that some individuals may experi-
ence harmful or adverse effects after meditating
(18). New studies of long-term meditators indicate
that challenging, difficult or functionally impairing
effects, which include hospitalization and suicidal-
ity, have a median duration of 1–3 years (19), and
tentatively estimate, based on an average 5% rate
of adverse events in the general psychotherapy lit-
erature, that in the USA alone almost 1 million of
individuals may experience negative events associ-
ated with meditation (20).
There is an important distinction in the medical
literature between serious adverse events (SAEs)
and adverse events (AEs). In the European Union
and the USA, SAEs are described within regula-
tions for the testing of new medical products in
clinical trials and specifically refer to occurrences
that result in death, significant disability or inca-
pacity, congenital anomaly or birth defect, are life-
threatening, or require hospitalization (21, 22).
The definition of other types of AEs is more
broadly construed as any ‘undesirable’ or ‘unto-
ward’ occurrences associated with, though not nec-
essarily caused, by the use of a medical product.
These regulations are relevant for the study of
MAEs in two ways: meditation-based clinical trials
across the EU and the USA are subjected to these
regulations and must report all SAEs; on the other
hand, they are not required to report other types
of adverse occurrences that fall outside of this list,
which is likely to lead to an under-reporting of
MAEs – a general problem found with randomized
controlled trials (23).
Within the psychotherapeutic literature, there is
growing evidence that psychological treatments can
be associated with AEs (13) with estimates ranging
from 3% to 10% of patients who have become
worse following psychotherapy (14). Similar find-
ings have been reported for physical relaxation,
which may in some individuals stimulate an increase
in anxiety, an adverse event documented as ‘relax-
ation-induced anxiety’ (15). Rather than referring
to these events as ‘undesirable’, which may be con-
fused with something that is merely ‘unhelpful’, this
literature has highlighted AEs as ‘harmful’, leaving
no doubt that these are negative occurrences, often
including symptom deterioration (24). In this
review, we will adopt a similar characterization of
MAEs as occurrences that are harmful or distress-
ing, though of varying levels of severity.
Despite a growing interest in this area, there has
been no systematic review addressing potential
AEs across the whole range of meditation reports.
Two recent reviews have only included the litera-
ture on mindfulness-based interventions and found
that these meditation interventions were no more
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likely to lead to harm than a wait-list control, or
they identified an overall very low rate of adverse
events (1% across 36 randomized controlled trials)
(25, 26). By contrast, the present study aims to
review the wide literature on MAEs by including
all types of empirical reports, regardless of their
methodological approach.
Aims of the study
The aim of this systematic review is to provide an
assessment of the major categories of adverse
events and its prevalence across the meditation lit-
erature.
Methods
This systematic review followed the PRISMA
guidelines, and it was registered on PROSPERO
(2016:CRD42016040177). As this is the first sys-
tematic review of the literature involving medita-
tion adverse events (MAEs), we utilized the ‘broad
sweep’ approach recommended by the Cochrane
Adverse Effects Methods Group (27) in order to
gain a general view of the variety of adverse events,
as well as attempting a preliminary estimate of
their prevalence. This approach is recommended
when specific adverse effects associated with a ther-
apeutic intervention are not known and it is not
possible to stipulate which ones will be the most
relevant for the review.
Search strategies
We searched PUBMED, PSYCINFO, SCOPUS,
EMBASE and AMED for articles published up to 31
October 2019. Our search strategy included the words
‘meditation’ or ‘mindfulness’ in combination with
terms concerning somatic, psychological, and neuro-
logical or cognitive adverse events (see Table S1).
Eligibility criteria
Our inclusion criteria consisted of studies employ-
ing a meditation technique or intervention with
adult participants (aged 18 years of age or older)
that reported original data on MAEs using any
type of methodological approach – case studies,
observational group studies (quantitative and
qualitative) and experimental studies (quasi-experi-
mental and randomized controlled trials) in any
published language.
Here, we consider MAEs the whole range of
experiences associated with the practice of medita-
tion, or meditation-based therapeutic interven-
tions, which are harmful or distressing. We
deemed eligible any study showing a harmful event
or deterioration of current physical or mental con-
dition that occurred during or after meditation
practice. On the other hand, we wanted to focus
specifically on meditation techniques, broadly
defined as a mental practice where an individual
brings the focus of attention to a particular object
(whether a word, image, sound, breathing or feel-
ing) or to the flow of conscious awareness. We thus
excluded other so-called mind–body interventions,
such as Qigong and Yoga involving the practice of
physical exercise or asanas, for which there are sep-
arate literatures on their adverse effects (28, 29).
Selection of studies
Two authors (KW, MF) independently reviewed
the titles, abstracts, and screened the methods sec-
tion of each study using the eligibility criteria. The
full text of potentially eligible studies was read in
full by 3 authors (MF, KW, EM). All disagree-
ments were discussed until resolved.
Data extraction
Data were extracted by one author (EM) and veri-
fied by a second author (MF). The data included
reports about sample size, type of meditation prac-
tice, length of practice, major clinical categories of
adverse events with a detailed breakup of symp-
toms, previous medical or psychiatric history, dura-
tion of adverse events and its prevalence. When
MAEs were reported in general terms but the speci-
fic symptoms were missing, we contacted authors of
studies to attempt obtaining missing data.
Risk of bias
Methodological quality was rated using the
National Institutes of Health Quality Assessment
Tools. We chose the tools that assessed case–con-
trol studies, observational cohort and cross-sec-
tional studies; for the experimental studies and
randomized clinical trials, we used the tools on
controlled intervention studies and before–after
(pre–post) studies with no control group. Two
authors (MF and EM) read and graded the quality
of studies. Grades where disagreement arose were
discussed until a consensus was reached. The grad-
ing system considered outcomes of high, medium
and low quality (see Table S2).
Data analysis
A total of 6742 articles were found in the database
search. Following the removal of duplicates, 5276
376
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records were identified and screened (see Fig. 1).
Of these, 5160 studies did not meet the inclusion
criteria, which left a total of 116 articles for full
text analysis. A total of 33 studies were excluded
because they did not assess adverse events, or did
not include original data (e.g. commentaries),
totalling 83 studies for the final analysis (see
Fig. 1). We considered that an MAE had occurred
if a study reported at least one event. Two authors
(MF and EM) reviewed the extracted data and cate-
gorized reported MAEs across broad (somatic, psy-
chiatric and neurological or cognitive) and specific
categories (such as pain, stress, fear or terror, cogni-
tive anomalies, visual or auditory hallucinations).
Some specific categories included a short range of
terms that were employed across studies. For exam-
ple, under ‘Visual or Auditory Hallucinations’ we
considered the terms ’visual hallucinations’, ’audi-
tory hallucinations’, ‘hearing voices’, and ‘unusual
visualisations’; for the ‘Fear and Terror’ category
we included the terms ‘fear’, ‘terror’, ‘panic attack’,
and ‘agoraphobia’. Other categories were comprised
of a wider range of terms which reflected the differ-
ent methods employed, from self-report to biologi-
cal instruments. For example, the ‘Stress’ category
included the terms ‘stress’, ‘tension’, ‘restlessness’,
‘elevated cortisol levels’, and ‘increased blood pres-
sure’; for the ‘Cognitive Anomalies’ category we
included the terms ‘disorientation to time and
place’, ‘confusion’, ‘attention problems’, ‘false mem-
ories’, ‘reduced memory accuracy’, and ‘perceptual
hypersensitivity’.
In addition, we calculated pooled prevalence
estimates for studies with experimental and
observational designs through Der Simonian and
Laird’s random effects. Freeman–Tukey double
arcsine transformation was used to stabilize vari-
ability in prevalence estimates. We excluded 10
studies that did not include the number of partici-
pants experiencing MAEs, and 1 study that only
sampled individuals who had experienced MAEs.
Given that case studies were equally not consid-
ered, a total of 57 reports were included in the
prevalence estimates.
Results
The 83 included articles (6464 meditation partici-
pants; exclusive of control condition participants)
were published between 1974 and 2019. There were
54 experimental studies (n = 2673), 14 observa-
tional studies (n = 4023) and 15 case studies
(n = 31). All except 3 of the observational studies
(88, 90, 94) employed quantitative methods, and
its two most recent reports consisted of large sur-
veys that accounted for 58% of the total sample
size. (12, 13) The studies employed a wide variety
of meditation techniques (see Table 1), though the
majority used either mindfulness or mindfulness-
based interventions (MBIs) (61; 71%), or transcen-
dental meditation (14; 16%).
Fifty-five studies (65%) mentioned the occur-
rence of at least one type of MAE. A total of 1102
meditators experienced adverse events: 59 for
experimental studies, 1012 for observational stud-
ies and 31 for case studies. All case studies
described clinical cases of individuals who reported
severe MAEs, such as psychosis, depersonalization
6742 Records identified 
through database searching 











50 Additional records identified 
through other articles and 
researchers
5276 Records after duplicates removed
116 Full-text 




28 Did not report 
assessment of 
MAEs
5 Did not report data




Fig. 1. PRISMA diagram for selection
of studies. [Colour figure can be viewed
at wileyonlinelibrary.com]
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and mania symptoms. Most randomized con-
trolled trials did not state whether they included all
types of AEs reported by participants or only
SAEs.
We used OpenMeta software to calculate the
pooled prevalence estimates and levels of hetero-
geneity. The total pooled prevalence of MAEs for
57 reports, not including case studies, was 8.3%
Fig. 2. Forest plots showing the pooled prevalence estimates of meditation adverse events for all studies. [Correction added on 10
October 2020, after first online publication: an incorrect version of Figure 2 was published, and this has been corrected.] [Colour fig-
ure can be viewed at wileyonlinelibrary.com]
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(95% CI 0.05–0.12), (see Fig. 2). The prevalence
differed widely according to the methodological
approach; for experimental studies, the pooled
prevalence was 3.7% (95% CI 0.02–0.05), and for
observational studies, it was 33.2% (95% CI 0.25–
0.41) (see Figure S1 and S2). Statistical heterogene-
ity was considerable: I2 = 95% for all studies;
I2 = 73% for experimental studies, and I2 = 95%
for observational studies. This high level of hetero-
geneity is likely to reflect the methodologically
diversity of studies and the lack of a standardized
assessment of adverse events (Figs 3 and 4).
Major categories of adverse events
Psychiatric MAEs were described in 40 studies
(49%). The most common symptoms were anxiety
(18 studies) and depression (15 studies). Relatively
common psychiatric adverse events included psy-
chotic or delusional symptoms (10 studies), disso-
ciation or depersonalization (9 studies), and fear or
terror (9 studies). Trauma re-experience, in which
participants relive or remember difficult, traumatic
memories, was also moderately common (9 stud-
ies). Six studies (11%) reported suicidal ideation
and behaviour, including three mentions of suicide
attempts across different studies (2, 3, 19). The
only study that sampled exclusively individuals
who experienced MAEs reported that 10 (17%) of
its participants had experienced suicidality.
Somatic MAEs were reported across 26 studies
(31%). The most common somatic AEs were stress
or physical tension (11 studies), followed by pain
(9 studies) and gastrointestinal problems (6 stud-
ies). Reports of localized pain varied from the
abdomen or stomach (86, 90) to neck pain. (102)
Most variables were assessed through self-report
instruments, though some variables included a
variety of psychophysiological and biological mea-
sures; for example, stress was measured via heart
rate, blood pressure, skin conductance and cortisol
measures, as well as self-report instruments.
Neurological or cognitive MAEs were reported
across 17 studies (20%). The most common MAEs
in this category were cognitive anomalous experi-
ences reported in 14 studies, including thought dis-
organization (3, 89), amnesia (97), perceptual
hypersensitivity (19) and impaired memory relia-
bility (34, 40). We also found three studies that
reported involuntary bodily movements and mus-
cle contractions while meditating. (19, 94, 105).
For 33 studies (64%), the AEs were experienced
during or immediately after the practice or inter-
vention. Longer-term effects of more than
6 months were reported by only 9 studies (17%),
Fig. 3. Proportion of broad types of meditation adverse
events. [Colour figure can be viewed at wileyonlinelibrary.com]
Fig. 4. Proportion of most common meditation adverse events. [Colour figure can be viewed at wileyonlinelibrary.com]
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all of which were either observational or case stud-
ies. For the observational studies, data were based
on retrospective self-reports.
There were mixed reports in the observational
studies concerning the association between length
of meditation practice and frequency of AEs.
Three of the earlier studies reported a positive
association: one study found that participants who
dropped out of meditation classes reported less
AEs than those who kept meditating, and the most
experienced meditators had higher symptoms of
anxiety, confusion and depression (84). Another
study found that participants with over 8 years of
meditation experience reported the highest fre-
quency of adverse effects, compared to those with
<2 years’ experience (93). A survey of 221 medita-
tors reported that length of meditation practice
was positively associated with anomalous experi-
ences, including auditory and visual hallucinations.
(92) However, the largest survey failed to find any
significant association (13).
Another variable that has been associated in the
literature with AEs is meditation retreats (13, 19),
where the practice is done more intensively. The
data from the observational studies show that 42%
(1689) of individuals had taken part in meditation
retreats, with most of these (1409) being partici-
pants in the two largest surveys (12, 13). For case
studies, retreat experience was not unusual though
considerably lower (5;16%).
One other result which cannot be ascertained
from the majority of studies concerns whether par-
ticipant factors, such as a past mental health his-
tory, are likely to make individuals more
vulnerable to MAEs. Most randomized controlled
trials are interventions designed to target individu-
als with particular mental health disorders, but
overall these data do not allow us to ascertain
whether individuals with a mental health history
are more vulnerable than others to experiencing
MAEs. The case studies, however, include such
data for most participants (unavailable for 2; 9%).
We found that most individuals (17; 55%) had no
mental health history prior to the adverse events
during or following meditation practice, compared
with 11 (36%) participants.
Discussion
We have systematically reviewed 83 studies pub-
lished from 1975 to 2019 containing an assessment
of adverse events in association with meditation
practice. Fifty-five of these studies, with a total of
1102 participants, reported at least one type of
meditation adverse event (MAE), which we catego-
rized into broad and specific categories. There is
no previous systematic review of this literature,
and our main aims were to address key questions
concerning the prevalence of MAEs and the major
categories of such adverse events. Additionally, we
examined the time period of MAEs. Overall, we
found that (i) the total pooled prevalence of MAEs
was 8.3% (95% CI 0.05–0.12); for experimental
studies, the prevalence was 3.7% (95% CI 0.02–
0.05), and for observational studies, it was 33.2%
(95% CI 0.25 to 0.41); (ii) AEs were varied and
included somatic, psychiatric and neurological/
cognitive reports; (iii) the most common symptoms
reported were anxiety, depression, cognitive
anomalies (e.g. thought disorganization), stress,
and visual/auditory hallucinations; (iv) most AEs
occurred during or immediately after the medita-
tion practice or intervention, though this result
must be read with caution given the very limited
number of longitudinal studies and the use of ret-
rospective self-report methods. Additionally, we
found that (v) there were insufficient data from
experimental and observational studies to examine
participant factors associated with MAEs, though
case studies reported that the majority of individu-
als did not have a history of mental health prob-
lems.
The results on the prevalence of MAEs were
inconsistent and require further scrutiny. There are
reasons to suppose that the literature is under-re-
porting these adverse events. Our initial pool of
almost 7000 citations resulted in only 83 original
reports across 45 years of publications. A similar
under-reporting has been found by two meta-anal-
yses of mindfulness-based therapeutic interven-
tions. Only 9 trials out of 47 (19%) (108) and 36
trials out of 231 (16%) (25) reported AEs. It is also
likely that the majority of randomized controlled
trials (RCTs) reporting MAEs only assessed seri-
ous adverse events (SAEs). For example, in a meta-
analysis of mindfulness-based cognitive therapy
for relapse prevention in recurrent depression over
half of the studies only reported SAEs (109). In the
RCTs included in the experimental studies of our
review, the majority that found no MAEs failed to
report whether they assessed only SAEs or also
other AEs of less severity.
This under-reporting might be one of the causes
of the discrepancy in the prevalence estimates
between experimental and observational studies.
Another possible reason is that individuals in the
observational studies are practicing meditation
within uncontrolled settings, in contrast with the
structured context of MBIs which include psychoe-
ducational sessions on how to manage distressing
experiences arising during meditation or at other
times (110). Note, however, that a small
387
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proportion of individuals in the observational
studies (139; 3.5%) reported undergoing medita-
tion-based therapy.
Observational studies might better reflect the
present context of meditation practice, with many
individuals practicing without face-to-face interac-
tion, either using books or phone Apps. Although
there are no estimates for the total universe of
meditation App users, the number of downloads
during 2019 for a single App, Headspace, was close
to 40 million. (111) One other possibility for the
higher prevalence of AEs in these studies was the
relatively common frequency of retreat attendance
(42% of the sample). It is unclear, however,
whether this retreat experience falls under the cate-
gory of a controlled, face-to-face setting, or an
uncontrolled one. For example, the popular Vipas-
sana 10-day retreats are undertaken in silence and
with very minimal interaction with any teacher
(112).
We found a variety of somatic, psychiatric and
neurological/cognitive symptoms. The most fre-
quently reported include those which meditation is
expected to alleviate, such as anxiety, depression
and stress. Various explanations have been put for-
ward for the association between meditation and
these symptoms, including by participants experi-
encing MAEs. These have suggested that adverse
events are either initial barriers or difficulties that
are ultimately beneficial for personal growth (3, 9,
88, 93, 105). Similar symptoms have been recorded
in the traditional meditation literature. For exam-
ple, one early compendium of Buddhist meditation
techniques from the 5th century CE, the Dhar-
matrata Meditation Scripture, reports that if the
meditation is not carried out properly, the mind
can become unstable, restless or confused, and the
meditator feel dull, confused and sunken (113).
Such adverse symptoms are not looked upon in a
positive light, as may be the case with some mod-
ern meditators, but as consequences of practicing
meditation incorrectly (114).
Other explanations put forth in the medical and
psychological literature include the intensity of
meditation practice (19, 115), the competence of
the teacher and participant vulnerabilities,
although the latter have sometimes been found to
enhance the positive effects of meditation – such as
for recurrently depressed individuals with higher
rates of childhood trauma (48, 110). Concerning
participant vulnerability, one factor that has been
suggested to precipitate MAEs (110), the analysis
of case studies indicated that the majority of indi-
viduals suffering from severe MAEs had no previ-
ous mental health record. This is an important
finding which needs to be further explored in
future studies.
The results of this systematic review give rise to
various difficult questions. For example, how can
adverse events be differentiated from distressing
experiences which can be understood as integral to
meditation practice? And what is the role of cul-
tural–religious context and individual appraisal in
framing meditation experiences either as harmful
or constructive events? Lindahl et al. (116) have
suggested that a person-centred approach is the
most adequate way of understanding the variety of
unusual experiences stimulated by meditation
practices. This type of approach relies less on for-
mal diagnosis and more on the practitioner’s
agency and autonomy in deciding when meditation
distressing experiences require additional support
through social, psychological or medical interven-
tions.
Before such questions can be properly
addressed, we need to better understand how
appraisals might play a moderating role in MAEs.
This matter has been raised elsewhere. For exam-
ple, the literature on schizotypal traits and psy-
chosis suggests that experiences which are usually
categorized as anomalous can be offered positive
appraisals, in which case they will not become dis-
tressing and harmful (117, 118). To put this into
the context of meditation, if we consider the expe-
rience of an altered sense of self, including the loss
of body awareness or loss of individual self
reported in some of the reviewed studies (93, 94), a
religious framework may appraise this as a positive
event, though for some it is likely to be appraised
negatively, for example as a negative realization of
aloneness or a loss of one’s fundamental sense of
identity. Further research into how appraisals
might moderate meditation adverse events is likely
to bring important insights.
This systematic review has a number of limita-
tions. The absence of standardized measures in the
literature, as well as the passive monitoring of AEs
(or exclusively reporting SAEs), is likely to have
led to an underestimation of the actual rate of
AEs, particularly in experimental studies. On the
other hand, the observational data preclude any
clear causality assessment between meditation
practice and AEs. In addition to the factors men-
tioned earlier, such as the high frequency of retreat
experiences in this sample, it is also possible that
participants predisposed to heightened levels of
anxiety and depression are more likely to begin or
maintain a meditation practice to manage their
symptoms – in support of this hypothesis, a recent
study of over 12,000 individuals who use the
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meditation App Calm has found that over 40%
reported mental health diagnoses (119).
There is a long away ahead before we can ascer-
tain for whom, when and under what circumstances
do particular types of negative meditation-related
experiences arise, and what are their long-term
effects. We urgently need to move from passive
monitoring of AEs to an active standard assess-
ment of meditation experiences which include
negative effects. This could be achieved by using a
combination of relevant validated scales (e.g. for
positive and negative affect, and depersonaliza-
tion), and, given the likely moderating role of
appraisals, assessing the frequency and interpreta-
tion of unusual experiences may prove particu-
larly important (120).
Significant advances in this area are also
likely to result from changing the way results
are reported. If studies were to provide the
individual-level data, even if in a supplement or
archive, instead of only reporting the group-
level data, this would generate the datasets we
are currently missing to analyse how individuals
with different baseline characteristics, or under-
taking meditation within different contexts, may
be variably affected.
How should clinicians address the results of this
systematic review, which indicates that MAEs are
not uncommon or rare, and articulate them with
the benefits of meditation practice, as well as the
popular interest in these practices? A first step is to
inform individuals of the possibility of these AEs.
Researchers and centres involved in the study of
meditation have the ethical duty of informing all
taking their courses about the existence and preva-
lence of MAEs, and clinical trials should include
consent forms that acknowledge that these adverse
events may occur.
A greater awareness of this topic would not
only help dealing more promptly with potential
adverse events, but it would have an important
additional benefit: dispel prejudice about those
who suffer them. Raising awareness of potential
AEs will disseminate a less hyped (6) and more
objective understanding of meditation as a prac-
tice that may lead to both positive and negative
experiences.
In conclusion, this first systematic review of medi-
tation adverse events covering almost 5 decades of
studies has found a wide range of potential negative
symptoms. The ethical obligation to do no harm
urges clinicians and researchers to promote prac-
tices of active monitoring of MAEs. Given the pop-
ularity of meditation practices, further research into
this area should become a priority.
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